<DOC>
	<DOC>NCT02449889</DOC>
	<brief_summary>This trial is investigating the efficacy and safety of highly purified human chorionic gonadotropin (HP-hCG) and recombinant human chorionic gonadotropin (rhCG) for triggering of final follicular maturation in women undergoing controlled ovarian stimulation</brief_summary>
	<brief_title>A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<criteria>Premenopausal females between the ages of 18 and 39 years Documented history of infertility Body mass index (BMI) between 17.5 and 32.0 kg/m2 Regular menstrual cycles Known endometriosis stage III and IV Known polycystic ovarian syndrome (PCOS) History of recurrent miscarriage History of more than three previous controlled ovarian stimulation cycles</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>